All Paths Lead Through Dosimetry: A Overview of the Ever-evolving Science of Dosimetry in Y90

Tuesday, April 1, 2025

8:30 AM – 9:45 AM CT

Location: Music City Center, 209 ABC

CE: 1.25

Content Level: 300 (advanced)

Coordinator(s)

Nora Tabori, MD (she/her/hers)

Associate Professor
MedStar Washington Hospital Center, United States
Shamar Young, MD

Professor
University of Arizona, United States

The goal of this course will be to educate attendees on the latest in y90 dosimetry. The speakers will present on the latest updates in the ever-changing world of dosimetry as well as discuss future directions. All aspects of dosimetry from target doses to heterogeneity index will be covered.

Learning Objectives:

Upon completion of the session participants will be able to describe advanced dosimetry techniques, including their strengths and weaknesses.
Upon completion of the session participants will be able to articulate the challenges of y90 dosimetry.
Upon completion of the session participants will be able to interpret dose volume histograms.

Presentations:

8:30 AM – 8:40 AM CT

Dosimetry: Basics and Challenges
Speaker: Nora Tabori, MD (she/her/hers) – MedStar Washington Hospital Center
8:40 AM – 8:50 AM CT

Particle Density and Specific Activity: Does It Matter?
Speaker: Beau B. Toskich, MD, FSIR – Department of Radiology, Division of Interventional Radiology, Mayo Clinic, Jacksonville, FL 32224, United States
8:50 AM – 9:00 AM CT

Dosimetry in HCC: Current State of the Art
Speaker: Shamar Young, MD – University of Arizona
9:00 AM – 9:10 AM CT

Dosimetry in MCRC: Where Do We Stand
Speaker: Nima Kokabi, MD – University of North Carolina - Chapel Hill
9:10 AM – 9:20 AM CT

Dosimetry in Non-HCC, Non-MRCC - Is It Just the Same Thing?
Speaker: William S. Rilling, MD, FSIR – Medical College of Wisconsin
9:20 AM – 9:30 AM CT

Dosimetry in combination radioembolization and immunotherapy: necessity?
Speaker: Laura Crocetti, MD, PhD (she/her/hers) – Università di Pisa
9:30 AM – 9:45 AM CT

Q&A